Detalhe da pesquisa
1.
Prognostic impact and causality of age on oncological outcomes in women with endometrial cancer: a multimethod analysis of the randomised PORTEC-1, PORTEC-2, and PORTEC-3 trials.
Lancet Oncol
; 2024 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38701815
2.
Molecular and Clinicopathologic Characterization of Mismatch Repair-Deficient Endometrial Carcinoma Not Related to MLH1 Promoter Hypermethylation.
Mod Pathol
; 37(3): 100423, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38191122
3.
International validation of two EORTC questionnaires for assessment of health-related quality of life for patients with high-grade non-Hodgkin lymphoma (QLQ-NHL-HG29) and low-grade non-Hodgkin lymphoma (QLQ-NHL-LG20).
Cancer
; 129(17): 2727-2740, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37204189
4.
Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry.
Br J Cancer
; 128(7): 1360-1368, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36690721
5.
MR-based follow-up after brachytherapy and proton beam therapy in uveal melanoma.
Neuroradiology
; 65(8): 1271-1285, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37249621
6.
An easy, fast, and accurate way for implementing the standards of care for the management of patients with endometrial carcinoma into daily clinical practice: the ESGO mobile app.
Int J Gynecol Cancer
; 33(8): 1181-1184, 2023 08 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37460218
7.
European Society of Gynaecological Oncology Guidelines for the Management of Patients with Vulvar Cancer - Update 2023.
Int J Gynecol Cancer
; 33(7): 1023-1043, 2023 07 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37369376
8.
p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial.
Mod Pathol
; 35(10): 1475-1483, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35752743
9.
Prognostic relevance of the molecular classification in high-grade endometrial cancer for patients staged by lymphadenectomy and without adjuvant treatment.
Gynecol Oncol
; 164(3): 577-586, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35078648
10.
Substantial Lymphovascular Space Invasion Is an Adverse Prognostic Factor in High-Risk Endometrial Cancer.
Int J Gynecol Pathol
; 41(3): 227-234, 2022 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34392268
11.
Vaginal brachytherapy management of stage I and II endometrial cancer.
Int J Gynecol Cancer
; 32(3): 304-310, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35256416
12.
A sexual rehabilitation intervention for women with gynaecological cancer receiving radiotherapy (SPARC study): design of a multicentre randomized controlled trial.
BMC Cancer
; 21(1): 1295, 2021 Dec 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34863145
13.
Phase II study of definitive chemoradiation for locally advanced squamous cell cancer of the vulva: An efficacy study.
Gynecol Oncol
; 163(1): 117-124, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34301412
14.
Patients' and clinicians' preferences in adjuvant treatment for high-risk endometrial cancer: Implications for shared decision making.
Gynecol Oncol
; 161(3): 727-733, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33712276
15.
Adjuvant therapy for endometrial cancer in the era of molecular classification: radiotherapy, chemoradiation and novel targets for therapy.
Int J Gynecol Cancer
; 31(4): 594-604, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33082238
16.
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma.
Int J Gynecol Cancer
; 31(1): 12-39, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33397713
17.
Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes.
Gynecol Oncol
; 159(3): 649-656, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32972785
18.
Efficacy and toxicity of postoperative external beam radiotherapy or chemoradiation for early-stage cervical cancer.
Int J Gynecol Cancer
; 30(12): 1878-1886, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32591371
19.
PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer.
Int J Gynecol Cancer
; 30(12): 2002-2007, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33046573
20.
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial.
Lancet Oncol
; 20(9): 1273-1285, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31345626